Literature DB >> 21295216

Intermittent explosive disorder: development of integrated research criteria for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.

Emil F Coccaro1.   

Abstract

This study was designed to develop a revised diagnostic criteria set for intermittent explosive disorder (IED) for consideration for inclusion in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V). This revised criteria set was developed by integrating previous research criteria with elements from the current DSM-IV set of diagnostic criteria. Evidence supporting the reliability and validity of IED-IR ("IED Integrated Criteria") in a new and well-characterized group of subjects with personality disorder is presented. Clinical, phenomenologic, and diagnostic data from 201 individuals with personality disorder were reviewed. All IED diagnoses were assigned using a best-estimate process (eg, kappa for IED-IR >0.85). In addition, subjects meeting IED-IR criteria had higher scores on dimensional measures of aggression and had lower global functioning scores than non-IED-IR subjects, even when related variables were controlled. The IED-IR criteria were more sensitive than the DSM-IV criteria only in identifying subjects with significant impulsive-aggressive behavior by a factor of 16. We conclude that the IED-IR criteria can be reliably applied and have sufficient validity to warrant consideration as DSM-V criteria for IED.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21295216     DOI: 10.1016/j.comppsych.2010.05.006

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  16 in total

1.  Cerebrospinal fluid glutamate concentration correlates with impulsive aggression in human subjects.

Authors:  Emil F Coccaro; Royce Lee; Paul Vezina
Journal:  J Psychiatr Res       Date:  2013-06-18       Impact factor: 4.791

2.  Verbal versus physical aggression in Intermittent Explosive Disorder.

Authors:  Amy E Look; Michael S McCloskey; Emil F Coccaro
Journal:  Psychiatry Res       Date:  2014-12-08       Impact factor: 3.222

3.  Intermittent Explosive Disorder and Substance Use Disorder: Analysis of the National Comorbidity Survey Replication Sample.

Authors:  Emil F Coccaro; Jennifer R Fanning; Royce Lee
Journal:  J Clin Psychiatry       Date:  2017-06       Impact factor: 4.384

4.  The latent structure of attention deficit/hyperactivity disorder in an adult sample.

Authors:  David K Marcus; Alyssa L Norris; Emil F Coccaro
Journal:  J Psychiatr Res       Date:  2012-04-03       Impact factor: 4.791

5.  DSM-5, psychiatric epidemiology and the false positives problem.

Authors:  J C Wakefield
Journal:  Epidemiol Psychiatr Sci       Date:  2015-02-13       Impact factor: 6.892

6.  Social cognition in Intermittent Explosive Disorder and aggression.

Authors:  Emil F Coccaro; Jennifer R Fanning; Sarah K Keedy; Royce J Lee
Journal:  J Psychiatr Res       Date:  2016-07-16       Impact factor: 4.791

7.  Comorbid intermittent explosive disorder and posttraumatic stress disorder: Clinical correlates and relationship to suicidal behavior.

Authors:  Jennifer R Fanning; Royce Lee; Emil F Coccaro
Journal:  Compr Psychiatry       Date:  2016-06-04       Impact factor: 3.735

8.  Substance use disorders: Relationship with intermittent explosive disorder and with aggression, anger, and impulsivity.

Authors:  Emil F Coccaro; Daniel J Fridberg; Jennifer R Fanning; Jon E Grant; Andrea C King; Royce Lee
Journal:  J Psychiatr Res       Date:  2016-06-16       Impact factor: 4.791

9.  White Matter Integrity Reductions in Intermittent Explosive Disorder.

Authors:  Royce Lee; Konstantinos Arfanakis; Arnold M Evia; Jennifer Fanning; Sarah Keedy; Emil F Coccaro
Journal:  Neuropsychopharmacology       Date:  2016-05-20       Impact factor: 7.853

10.  Attention deficit hyperactivity disorder characteristics: II. Clinical correlates of irritable mood.

Authors:  Paul J Ambrosini; David S Bennett; Josephine Elia
Journal:  J Affect Disord       Date:  2012-08-04       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.